Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

BML-190

BML-190 (IMMA) is a potent and selective CB2 receptor ligand (Ki values are 435 nM and > 2 μM for CB2 and CB1 respectively) . IC50 Value: 435 nM (Ki CB2) Target:CB2 receptor in vitro: BML-190 increases the accumulation of cAMP, via forskolin-stimulated mechanism in HEK-293 cells. Alternate studies suggest that BML-190 reduces the toxicity of culture supernatants to SH-SY5Y human neutroblastoma cells. Various research suggests that BML-190 is an essential tool in studying the proliferation of neuroblastoma. BML-190 diminishes LPS-induced NO and IL-6 production in a concentration-dependent manner. BML-190 also inhibits LPS-induced PGE2 production and COX-2 induction. in vivo:

Product Specifications

CAS Number

2854-32-2

Product Name Alternative

Indomethacin morpholinylamide; IMMA

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

Cannabinoid Receptor

Type

Reference compound

Related Pathways

GPCR/G Protein; Neuronal Signaling

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/BML-190.html

Purity

99.53

Solubility

DMSO : 50 mg/mL (ultrasonic)

Smiles

CC(N1C(C2=CC=C(Cl)C=C2)=O)=C(CC(N3CCOCC3)=O)C4=C1C=CC(OC)=C4

Molecular Formula

C23H23ClN2O4

Molecular Weight

426.89

Precautions

H302, H315, H319, H335

References & Citations

[1]Zhang, Qiang; Ma, Peng; Cole, Richard B.; Wang, Guangdi In vitro metabolism of indomethacin morpholinylamide (BML-190), an inverse agonist for the peripheral cannabinoid receptor (CB2) in rat liver microsomes. European Journal of Pharmaceutical Sciences (2010), 41 (1), 163-172.|[2]Klegeris, Andis; Bissonnette, Christopher J.; McGeer, Patrick L. Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor. British Journal of Pharmacology (2003), 139 (4), 775-786.|[3]New DC, Wong YH. BML-190 and AM251 act as inverse agonists at the human cannabinoid CB2 receptor: signalling via cAMP and inositol phosphates. FEBS Lett. 2003 Feb 11;536 (1-3) :157-60.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

PNPLA3 Human Gene Knockout Kit (CRISPR)
KN209577LP 1 Kit

PNPLA3 Human Gene Knockout Kit (CRISPR)

Sign In for Pricing
View Details
Rabeprazole-d3 Sulfide
TRC-R070512-25MG 25 mg

Rabeprazole-d3 Sulfide

Sign In for Pricing
View Details
Nkx3.1 (NKX3-1) Mouse Monoclonal Antibody [Clone ID: OTI1C2]
CF805293 100 µg

Nkx3.1 (NKX3-1) Mouse Monoclonal Antibody [Clone ID: OTI1C2]

Sign In for Pricing
View Details
Mouse Cdyl activation kit by CRISPRa
GA200688 1 Kit

Mouse Cdyl activation kit by CRISPRa

Sign In for Pricing
View Details
Sermorelin Acetate
TRC-S280028-50MG 50 mg

Sermorelin Acetate

Sign In for Pricing
View Details
Human PHF20 activation kit by CRISPRa
GA109662 1 Kit

Human PHF20 activation kit by CRISPRa

Sign In for Pricing
View Details